SCHEMBL4671355

SCHEMBL4671355

CCOC(=O)CC(NCC(CC(C)C)N1C(=O)N(Cc2ccc(NC(=O)Nc3ccccc3C)c(OC)c2)C(C)(C)C1=O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 18/20 0.42
ITGA4 P13612 18/20 0.42
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8361449 1.00 ITGB1 (0.42) ITGB1ITGA4MEN1KMT2A
SCHEMBL4678413 0.93 ITGB1 (0.47) ITGB1ITGA4
SCHEMBL8358419 0.93 ITGB1 (0.47) ITGB1ITGA4
Hydrochloric Acid SCHEMBL4674432 0.93 ITGB1 (0.47) ITGB1ITGA4
Hydrochloric Acid SCHEMBL4674425 0.93 ITGB1 (0.47) ITGB1ITGA4
Hydrochloric Acid SCHEMBL4674418 0.93 ITGB1 (0.47) ITGB1ITGA4
SCHEMBL8358384 0.92 ITGA4 (0.41) ITGB1ITGA4MEN1KMT2A
SCHEMBL4675188 0.92 ITGA4 (0.41) ITGB1ITGA4MEN1KMT2A
SCHEMBL4671417 0.91 ITGA4 (0.40) ITGB1ITGA4MEN1KMT2A
SCHEMBL8361037 0.91 ITGA4 (0.40) ITGB1ITGA4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1414444-B1 NOVEL IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VLA-4 ANTAGONISTS SANOFI AVENTIS DEUTSCHLAND (DE) 2008-04-09 EP disclosed
EP-1414444-A1 NOVEL IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VLA-4 ANTAGONISTS Aventis Pharma Deutschland GmbH (DE) 2004-05-06 EP disclosed
WO-2003011288-A1 NOVEL IMIDAZOLIDINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS VLA-4 ANTAGONISTS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-02-13 WO disclosed